Citius Pharmaceuticals Inc. (CTXR) is primed for evolution with the beta value of 1.58

For the readers interested in the stock health of Citius Pharmaceuticals Inc. (CTXR). It is currently valued at $2.25. When the transactions were called off in the previous session, Stock hit the highs of $2.90, after setting-off with the price of $2.49. Company’s stock value dipped to $2.14 during the trading on the day. When the trading was stopped its value was $2.06.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Recently in News on February 19, 2021, Citius Pharmaceuticals Announces Closing of $76.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules. Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) (“Citius” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has closed its previously announced sale of an aggregate of 50,830,566 shares of its common stock and accompanying warrants to purchase up to an aggregate of 25,415,283 shares of its common stock, at a purchase price of $1.505 per share and accompanying warrant in a registered direct offering priced at-the-market under Nasdaq rules. You can read further details here

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .


Citius Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.90 on 02/22/21, with the lowest value was $1.00 for the same time period, recorded on 01/04/21.

Citius Pharmaceuticals Inc. (CTXR) full year performance was 184.77%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Citius Pharmaceuticals Inc. shares are logging 4.17% during the 52-week period from high price, and 442.17% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.41 and $2.16.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 145128162 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Citius Pharmaceuticals Inc. (CTXR) recorded performance in the market was 120.59%, having the revenues showcasing 138.47% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 127.69M, as it employees total of 10 workers.

Analysts verdict on Citius Pharmaceuticals Inc. (CTXR)

During the last month, 0 analysts gave the Citius Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 1.13, with a change in the price was noted +1.20. In a similar fashion, Citius Pharmaceuticals Inc. posted a movement of +114.29% for the period of last 100 days, recording 5,784,281 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CTXR is recording 0.02 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.01.

Citius Pharmaceuticals Inc. (CTXR): Technical Analysis

Raw Stochastic average of Citius Pharmaceuticals Inc. in the period of last 50 days is set at 66.32%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 62.86%. In the last 20 days, the company’s Stochastic %K was 72.68% and its Stochastic %D was recorded 70.29%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Let’s take a glance in the erstwhile performances of Citius Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 120.59%. Additionally, trading for the stock in the period of the last six months notably improved by 114.29%, alongside a boost of 184.77% for the period of the last 12 months. The shares increased approximately by 65.44% in the 7-day charts and went down by 80.00% in the period of the last 30 days. Common stock shares were driven by 138.47% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free


Please enter your comment!
Please enter your name here